Ligand Pharmaceuticals
Jupiter, Floridaligand.com
Overview
Ligand Pharmaceuticals is a biopharmaceutical company that operates as a royalty aggregator, investing in the clinical development and commercialization of high-value medicines while licensing its proprietary technology platforms, Captisol and NITRICIL, to global pharmaceutical partners.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Zerion Pharma | Jun 2026 | VC Round | Lead |
| Lona Biotherapeutics Ltd. | Dec 2025 | Private Placement | Co-investor |
| Castle Creek Biosciences | Feb 2025 | Debt | Lead |
| Palvella Therapeutics | Dec 2024 | Private Placement | Co-investor |
| invIOs GmbH | Oct 2024 | Series A | Co-investor |
Key People
Melanie Herman
Executive Director Investor Relations and FP&A
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
